advertisement
Duan X 38
Showing records 1 to 25 | Display all abstracts from Duan X106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Sun X
Ophthalmology and therapy 2023; 12: 341-353
105778 Effects of Tafluprost on Ocular Blood Flow
Zhang X
Ophthalmology and therapy 2022; 11: 1991-2003
106010 Combination of Trabeculectomy and Primary Pars Plana Vitrectomy in the Successful Treatment of Angle-Closure Glaucoma with BEST1 Mutations: Self-Controlled Case Series
Fang Y
Ophthalmology and therapy 2022; 11: 2271-2284
106408 Longitudinal in vivo Ca imaging reveals dynamic activity changes of diseased retinal ganglion cells at the single-cell level
Li L
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: e2206829119
105778 Effects of Tafluprost on Ocular Blood Flow
Zhou X
Ophthalmology and therapy 2022; 11: 1991-2003
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Yao K
Ophthalmology and therapy 2023; 12: 341-353
106010 Combination of Trabeculectomy and Primary Pars Plana Vitrectomy in the Successful Treatment of Angle-Closure Glaucoma with BEST1 Mutations: Self-Controlled Case Series
Duan X
Ophthalmology and therapy 2022; 11: 2271-2284
106408 Longitudinal in vivo Ca imaging reveals dynamic activity changes of diseased retinal ganglion cells at the single-cell level
Feng X
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: e2206829119
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Liu Q
Ophthalmology and therapy 2023; 12: 341-353
106408 Longitudinal in vivo Ca imaging reveals dynamic activity changes of diseased retinal ganglion cells at the single-cell level
Fang F
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: e2206829119
105778 Effects of Tafluprost on Ocular Blood Flow
Zhao Y
Ophthalmology and therapy 2022; 11: 1991-2003
106010 Combination of Trabeculectomy and Primary Pars Plana Vitrectomy in the Successful Treatment of Angle-Closure Glaucoma with BEST1 Mutations: Self-Controlled Case Series
Chen L
Ophthalmology and therapy 2022; 11: 2271-2284
106408 Longitudinal in vivo Ca imaging reveals dynamic activity changes of diseased retinal ganglion cells at the single-cell level
Miller DA
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: e2206829119
106010 Combination of Trabeculectomy and Primary Pars Plana Vitrectomy in the Successful Treatment of Angle-Closure Glaucoma with BEST1 Mutations: Self-Controlled Case Series
Shi J
Ophthalmology and therapy 2022; 11: 2271-2284
105778 Effects of Tafluprost on Ocular Blood Flow
Yang X
Ophthalmology and therapy 2022; 11: 1991-2003
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Zhang H
Ophthalmology and therapy 2023; 12: 341-353
106010 Combination of Trabeculectomy and Primary Pars Plana Vitrectomy in the Successful Treatment of Angle-Closure Glaucoma with BEST1 Mutations: Self-Controlled Case Series
Liu J
Ophthalmology and therapy 2022; 11: 2271-2284
105778 Effects of Tafluprost on Ocular Blood Flow
Zhou D
Ophthalmology and therapy 2022; 11: 1991-2003
106408 Longitudinal in vivo Ca imaging reveals dynamic activity changes of diseased retinal ganglion cells at the single-cell level
Zhang S
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: e2206829119
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Xing X
Ophthalmology and therapy 2023; 12: 341-353
105778 Effects of Tafluprost on Ocular Blood Flow
Chen B
Ophthalmology and therapy 2022; 11: 1991-2003
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Fang A
Ophthalmology and therapy 2023; 12: 341-353
106408 Longitudinal in vivo Ca imaging reveals dynamic activity changes of diseased retinal ganglion cells at the single-cell level
Zhuang P
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: e2206829119
106010 Combination of Trabeculectomy and Primary Pars Plana Vitrectomy in the Successful Treatment of Angle-Closure Glaucoma with BEST1 Mutations: Self-Controlled Case Series
Sun Y; Wang J
Ophthalmology and therapy 2022; 11: 2271-2284
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Duan X
Ophthalmology and therapy 2023; 12: 341-353
